These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26969516)

  • 1. Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.
    Frandsen CS; Dejgaard TF; Madsbad S
    Lancet Diabetes Endocrinol; 2016 Sep; 4(9):766-780. PubMed ID: 26969516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-insulin pharmacological therapies for treating type 1 diabetes.
    Frandsen CS; Dejgaard TF; Madsbad S; Holst JJ
    Expert Opin Pharmacother; 2018 Jun; 19(9):947-960. PubMed ID: 29991320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of non-insulin therapies for type 1 diabetes.
    Garg SK; Michels AW; Shah VN
    Diabetes Technol Ther; 2013 Nov; 15(11):901-8. PubMed ID: 24131372
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes Update: New Pharmacotherapy for Type 2 Diabetes.
    Choby B
    FP Essent; 2017 May; 456():27-35. PubMed ID: 28530382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementing insulin therapy to achieve glycemic control.
    Barnett AH
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
    Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
    Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
    Hermansen K; Mortensen LS
    Drug Saf; 2007; 30(12):1127-42. PubMed ID: 18035865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-insulin treatments for Type 1 diabetes: critical appraisal of the available evidence and insight into future directions.
    Wright LA; Hirsch IB
    Diabet Med; 2019 Jun; 36(6):665-678. PubMed ID: 30801765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological management of type 2 diabetes mellitus: an update.
    El-Kaissi S; Sherbeeni S
    Curr Diabetes Rev; 2011 Nov; 7(6):392-405. PubMed ID: 21846326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.
    Ferrannini E; DeFronzo RA
    Eur Heart J; 2015 Sep; 36(34):2288-96. PubMed ID: 26063450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
    Thrasher J
    Am J Cardiol; 2017 Jul; 120(1S):S4-S16. PubMed ID: 28606343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective.
    Thompson PL; Davis TME
    Clin Ther; 2017 May; 39(5):1012-1025. PubMed ID: 27863704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of diabetes and diabetes medications on bone health.
    Gilbert MP; Pratley RE
    Endocr Rev; 2015 Apr; 36(2):194-213. PubMed ID: 25738213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into antidiabetic therapies: a report from the 43rd annual meeting of the European Association for the Study of Diabetes.
    Rabasseda X
    Timely Top Med Cardiovasc Dis; 2007 Oct; 11():E28. PubMed ID: 18297140
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral antidiabetes agents for the management of inpatient hyperglycaemia: so far, yet so close.
    Koufakis T; Mustafa OG; Zebekakis P; Kotsa K
    Diabet Med; 2020 Sep; 37(9):1418-1426. PubMed ID: 32445407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond insulin: what else might help?
    Scheiner G
    Diabetes Self Manag; 2014; 31(1):30, 32-4. PubMed ID: 24640060
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential role of non-insulin adjunct therapy in Type 1 diabetes.
    George P; McCrimmon RJ
    Diabet Med; 2013 Feb; 30(2):179-88. PubMed ID: 22804102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.
    Kumar A
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():21-5. PubMed ID: 23280862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes.
    Paneni F; Lüscher TF
    Am J Med; 2017 Jun; 130(6S):S18-S29. PubMed ID: 28526186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.
    Tahrani AA; Barnett AH; Bailey CJ
    Nat Rev Endocrinol; 2016 Oct; 12(10):566-92. PubMed ID: 27339889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.